Remedium Lifecare Ltd — Updates, 13-05-2025: Company Update

Remedium Lifecare has announced a board meeting to discuss the financial results for the quarter and half-year. The company is enhancing its CDMO and R&D capabilities to transition from a trader to an integrated pharmaceutical solutions provider. It recently secured a ₹182.7 crore multi-year export contract targeting the UK and European markets. Upgrades include advanced testing equipment and expanded lab space, aimed at improving operational efficiency and supporting global product development. Its Singapore subsidiary is partnering to commercialize sustainable API manufacturing technologies, boosting innovation and sustainability.